Polymyositis

Type: Keyphrase
Name: Polymyositis
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board

- iBio, Inc. ( NYSE MKT : IBIO ), a leading provider of biotechnology for developing and manufacturing plant-made pharmaceutical products, has appointed Thomas A. Medsger Jr., M.D., to its clinical advisory board.Dr. Medsger is an internationally recognized ... [Published MarketWired - 3 hours ago]
First reported Aug 27 2014 - Updated Aug 28 2014 - 1 reports

Roche, InterMune a Strategic Play in Midst of Inversions

NEW YORK (The Deal) -- In 2003, Foster City, Calif.'s Gilead Sciences apurchased Durham, N.C.'s Triangle Pharmaceuticals for $464 million. Daniel Welch, CEO of Triangle at the time, was a key player in the transaction.Soon after his gig was up at Triangle, ... [Published The Street Latest - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Inclusion Body Myositis Market - Global Industry Analysis and Forecast 2014 – 2020

Transparency Market Research Reports incorporated a definite business overview and investigation inclines on “Inclusion Body Myositis Market”. This report likewise incorporates more illumination about fundamental review of the business including definitions, ... [Published MyNewsDesk - Aug 27 2014]
First reported Aug 27 2014 - Updated Aug 27 2014 - 1 reports

Get Well Wednesday: Will Downing Shares His Journey to Health

Will Downing certainly has come far by grace. The crooner, whose latest release is Euphoria , was diagnosed with polymyositis in 2007 a debilitating chronic inflammatory disease of the muscles which at one point left him bedridden.“I’ve had my own health ... [Published Black America Web - Aug 27 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

CVS Caremark's Accordant Health Services Receives NCQA Disease Management Accreditation

PRESS RELEASEWOONSOCKET, R.I. , Aug. 18, 2014 /PRNewswire/ -- CVS Caremark (NYSE: CVS) announced today that its Accordant Health Services division has received full NCQA Patient and Practitioner Oriented Disease Management (DM) accreditation for programs ... [Published Pharmacy Times - Aug 25 2014]
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

Idera and TMA collaborate to develop treatment for myositis

Idera Pharmaceuticals, Inc. and The Myositis Association, or TMA, have announced a collaboration to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor, or TLR, antagonism. Under the collaboration, ... [Published Individual.com - Aug 23 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

CVS Caremark earns NCQA disease management accreditation certification for Accordant Health Services

Pharmacy CVS Caremark (NYSE:CVS) said on Monday that its Accordant Health Services division has been awarded the full NCQA Patient and Practitioner Oriented Disease Management (DM) accreditation in support of several diseases for programmes.The company ... [Published Individual.com - Aug 19 2014]
First reported Aug 13 2014 - Updated Aug 13 2014 - 1 reports

Idera Pharmaceuticals and The Myositis Association Advance the Clinical Development of IMO-8400 for Myositis

CAMBRIDGE, Mass. & ALEXANDRIA, Va.--(BUSINESS WIRE)--Aug. 7, 2014-- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis ... [Published Drugs.com - Aug 13 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 4 reports

Idera, TMA to advance clinical development of myositis treatment

Idera Pharmaceuticals and The Myositis Association (TMA) have collaborated to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor (TLR) antagonism. ... [Published PBR - News - Aug 08 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

New Inclusion Body Myositis Study Findings Reported from Tufts University (Aberrant cell cycle reentry in human and experimental inclusion body...

New Inclusion Body Myositis Study Findings Reported from Tufts University (Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis)By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results ... [Published 4 Traders - Aug 06 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Question regarding Pregnancy with PM

I'm having a hard time finding information about pregnancy and Polymyositis.I am 22 weeks, 6 days along; I have a regular OB, I see a Specialist and they work together with my Rheumy.I have ultrasounds every four -five weeks to measure the progress/development ... [Published HealthBoards - Aug 06 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Sjogren Syndrome

Medical Treatment Follow-up Web Links Sjögren's syndrome is a disorder of the moisture-producing glands, such as the tear glands (lacrimal glands) and the salivary glands. These glands become infiltrated with white blood cells (lymphocytes) that are part ... [Published eMedicine Health - Jul 30 2014]

Quotes

...the history of systemic sclerosis clinical research and the current state of the art," said Terence Ryan, Ph D , iBio's chief scientific officer. "We look forward to working with Dr. Medsger to design successful clinical trials with clinically meaningful outcomes."
"We believe this is a good strategic fit for Roche" Liisa Bayko, biotechnology analyst at JMP Securities Inc., who followed InterMune, told The Deal in an interview
...to improving the overall health and well-being of the patients we support," said Troyen A Brennan, MD, Chief Medical Officer of CVS Caremark. "Our coordinated, holistic care management programs provide patients with the support and tools necessary to help them holistically manage their rare diseases while working to improve health outcomes and reduce avoidable utilization."
...living with this rare and painful inflammatory muscle disease," said Kate Haviland, vice president of Rare Diseases at Idera Pharmaceuticals. "As we prepare to move our investigational drug candidate IMO-8400 into clinical development for polymyositis and dermatomyositis, we believe that TMA will be instrumental in increasing patient and physician awareness and excitement for opportunities to participate in clinical research involving TLR antagonism."

More Content

All (32) | News (25) | Reports (0) | Blogs (7) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Dr. Thomas A. Medsger Jr. Joins iBio Clinical A... [Published MarketWired - 3 hours ago]
Roche, InterMune a Strategic Play in Midst of I... [Published The Street Latest - Aug 27 2014]
Inclusion Body Myositis Market - Global Industr... [Published MyNewsDesk - Aug 27 2014]
Get Well Wednesday: Will Downing Shares His Jou... [Published Black America Web - Aug 27 2014]
CVS Caremark's Accordant Health Services Receiv... [Published Pharmacy Times - Aug 25 2014]
Idera and TMA collaborate to develop treatment ... [Published Individual.com - Aug 23 2014]
VERTEX PHARMACEUTICALS : Patent Issued for Isot... [Published 4 Traders - Aug 20 2014]
CVS Caremark earns NCQA disease management accr... [Published Individual.com - Aug 19 2014]
CVS Caremark’s Accordant Health Services Receiv... [Published Live Trading News - Aug 18 2014]
Agonists of neurotrophin receptors and their us... [Published PharmCast - Aug 14 2014]
Idera Pharmaceuticals and The Myositis Associat... [Published Drugs.com - Aug 13 2014]
Idera, TMA to advance clinical development of m... [Published PBR - News - Aug 08 2014]
Idera collaborates with TMA to advance new pote... [Published News-Medical.Net - Aug 07 2014]
Partnership Formed for Development of Myositis ... [Published Newswise - Aug 07 2014]
Idera Pharmaceuticals and The Myositis Associat... [Published Business Wire Health News - Aug 07 2014]
New Inclusion Body Myositis Study Findings Repo... [Published 4 Traders - Aug 06 2014]
Question regarding Pregnancy with PM [Published HealthBoards - Aug 06 2014]
The injury-induced myokine insulin-like 6 is pr... [Published 7thSpace - Aug 04 2014]
Sjogren Syndrome [Published eMedicine Health - Jul 30 2014]
Questcor (QCOR) Misses on Q2 Earnings, Beats on... [Published Yahoo! Finance - Jul 25 2014]
Auto-Immune Self-Care Board? [Published HealthBoards - Apr 20 2014]
Targeted transforming growth factor-beta-bound ... [Published PharmCast - Apr 17 2014]
Mallinckrodt to acquire Questcor Pharmaceutical... [Published PharmaBiz - Apr 08 2014]
Idera Pharmaceuticals announces expansion of pi... [Published Pharmaceutical Business Review - Mar 14 2014]
Idera Pharmaceuticals Announces Expansion of Pi... [Published EON Science - Mar 13 2014]
Idera Pharmaceuticals Announces Expansion of Pi... [Published Business Wire Science: Science News - Mar 13 2014]
Idera Pharmaceuticals Announces Expansion of Pi... [Published Business Wire Health News - Mar 13 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
Tetrameric cytokines with improved biological a... [Published PharmCast - Dec 17 2013]
Inhibitors of antigen presentation by MHC class... [Published PharmCast - Dec 15 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Idera, TMA to advance clinical development of m... [Published PBR - News - Aug 08 2014]
Idera Pharmaceuticals and The Myositis Association (TMA) have collaborated to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor (TLR) antagonism. ...
Idera Pharmaceuticals and The Myositis Associat... [Published Business Wire Health News - Aug 07 2014]
CAMBRIDGE, Mass. & ALEXANDRIA, Va.--(BUSINESS WIRE)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis Association (TMA), ...
Question regarding Pregnancy with PM [Published HealthBoards - Aug 06 2014]
I'm having a hard time finding information about pregnancy and Polymyositis.I am 22 weeks, 6 days along; I have a regular OB, I see a Specialist and they work together with my Rheumy.I have ultrasounds every four -five weeks to measure the progress/development ...
Auto-Immune Self-Care Board? [Published HealthBoards - Apr 20 2014]
Hi board community,I am posting in the autoimmune forum, because I am waiting for my initial visit with a rheumatologist. Lab work was: ANA 1,280, positive for rheumatoid factor, low level of c-reactive protein. Symptoms: Hand and wrist arthritis, swelling ...
Idera Pharmaceuticals Announces Expansion of Pi... [Published EON Science - Mar 13 2014]
CAMBRIDGE, Mass.--(EON: Enhanced Online News)--Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing a novel therapeutic approach for the treatment of autoimmune disorders and genetically defined forms of B-cell ...
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.